Two Sigma Investments, LP Guardant Health, Inc. Call Options Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $404,957 - $541,897	4,100 Added 136.67%	7,100 $888,000
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $329,310 - $497,040	3,000 New	3,000 $373,000
Q2 2020 Aug 14, 2020	SELL	$60.49 - $97.5 $592,802 - $955,500	-9,800 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $336,528 - $506,217	5,700 Added 139.02%	9,800 $682,000
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $101,133 - $140,726	-1,700 Reduced 29.31%	4,100 $320,000
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $363,022 - $639,740	5,800 New	5,800 $370,000

331

116M

680K

1.66M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.